479 related articles for article (PubMed ID: 27225288)
21. A comparison of postprocedural anticoagulation in high-risk patients undergoing WATCHMAN device implantation.
Cohen JA; Heist EK; Galvin J; Lee H; Johnson M; Fitzsimons M; Slattery K; Ghoshhajra B; Sakhuja R; Ha G; Forsch M; Shi L; Danik J; Dal-Bianco J; Sanborn D; Hung J; Ruskin J; Gurol ME; Mansour M
Pacing Clin Electrophysiol; 2019 Oct; 42(10):1304-1309. PubMed ID: 31479160
[TBL] [Abstract][Full Text] [Related]
22. Outcome of left atrial appendage occlusion in high-risk patients.
Masoud A; Bartoletti S; Fairbairn T; Khurana A; Velavan P; Morrison WL; Khalatbari A; Aggarwal S; Sharma N; Kirchhof P; Gupta D
Heart; 2018 Apr; 104(7):594-599. PubMed ID: 29122931
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
Grosset-Janin D; Barth E; Bertrand B; Detante O
Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
[TBL] [Abstract][Full Text] [Related]
24. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
[TBL] [Abstract][Full Text] [Related]
26. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
27. Left atrial appendage occluder implantation in Europe: indications and anticoagulation post-implantation. Results of the European Heart Rhythm Association Survey.
Tilz RR; Potpara T; Chen J; Dobreanu D; Larsen TB; Haugaa KH; Dagres N
Europace; 2017 Oct; 19(10):1737-1742. PubMed ID: 29016910
[TBL] [Abstract][Full Text] [Related]
28. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
[TBL] [Abstract][Full Text] [Related]
30. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes following percutaneous left atrial appendage closure in patients with atrial fibrillation and contraindications to anticoagulation.
Regueiro A; Cruz-Gonzalez I; Bethencourt A; Nombela-Franco L; Champagne J; Asmarats L; Jiménez-Quevedo P; Rodriguez-Gabella T; Rama-Merchan JC; Puri R; O'Hara G; Rodés-Cabau J
J Interv Card Electrophysiol; 2018 Jun; 52(1):53-59. PubMed ID: 29564664
[TBL] [Abstract][Full Text] [Related]
32. The cessation of oral anticoagulation following left atrial appendage surgery.
Mangrolia N; Punjabi P
Future Cardiol; 2018 Sep; 14(5):407-415. PubMed ID: 30232906
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial.
Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Foley D; Sievert H; Mazzone P; De Potter T; Vireca E; Stein K; Bergmann MW;
Heart Rhythm; 2017 Sep; 14(9):1302-1308. PubMed ID: 28577840
[TBL] [Abstract][Full Text] [Related]
34. WATCHMAN implantation in patients with a history of atrial fibrillation and intracranial hemorrhage.
Hucker WJ; Cohen JA; Gurol ME; Heist EK; Gianni C; Galvin J; Atkins D; Bommana S; Di Biase L; Ruskin J; Mohanty S; Horton R; Lakkireddy D; Natale A; Mansour M
J Interv Card Electrophysiol; 2020 Nov; 59(2):415-421. PubMed ID: 31833012
[TBL] [Abstract][Full Text] [Related]
35. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
[TBL] [Abstract][Full Text] [Related]
36. Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry.
Wintgens L; Romanov A; Phillips K; Ballesteros G; Swaans M; Folkeringa R; Garcia-Bolao I; Pokushalov E; Boersma L
Europace; 2018 Nov; 20(11):1783-1789. PubMed ID: 29547906
[TBL] [Abstract][Full Text] [Related]
37. Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry).
Lempereur M; Aminian A; Freixa X; Gafoor S; Shakir S; Omran H; Berti S; Santoro G; Kefer J; Landmesser U; Nielsen-Kudsk JE; Cruz-Gonzalez I; Kanagaratnam P; Nietlispach F; Ibrahim R; Sievert H; Schillinger W; Park JW; Gloekler S; Tzikas A
Am J Cardiol; 2017 Aug; 120(3):414-420. PubMed ID: 28595859
[TBL] [Abstract][Full Text] [Related]
38. [Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].
Fontos G; Andréka P; Temesvári A; Wéber D; Szatmári A
Orv Hetil; 2010 May; 151(18):725-34. PubMed ID: 20409999
[TBL] [Abstract][Full Text] [Related]
39. Incidence, Characteristics, and Clinical Course of Device-Related Thrombus After Watchman Left Atrial Appendage Occlusion Device Implantation in Atrial Fibrillation Patients.
Kubo S; Mizutani Y; Meemook K; Nakajima Y; Hussaini A; Kar S
JACC Clin Electrophysiol; 2017 Dec; 3(12):1380-1386. PubMed ID: 29759668
[TBL] [Abstract][Full Text] [Related]
40. [Patient selection for the implantation of a left atrial appendage occluder in primary and secondary prevention of cardioembolic stroke in atrial fibrillation].
Israel CW; Ridjab D; Tschishow WN; Buddecke J
Herzschrittmacherther Elektrophysiol; 2013 Mar; 24(1):25-32. PubMed ID: 23625310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
